Back
Ingevity Vs. NovoCure Industry Stock Comparison
Sell
18
NGVT
Ingevity
Last Price:
45.86
Seasonality Move:
-0.07%
Buy
75
NVCR
NovoCure
Last Price:
33.40
Seasonality Move:
-5.24%
Sell
18
Ingevity (NGVT)
is a Sell
Is Ingevity a Buy, Sell or Hold?
- The current Ingevity [NGVT] share price is $45.83. The Score for NGVT is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- NGVT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
75
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NGVT Stock Price Chart
NGVT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.99 | Buy |
Relative Strength Index (14 RSI): | 50.09 | Buy |
Chaikin Money Flow: | -159146 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.72 - 48.4) | Sell |
Bollinger Bands (100): | (34.99 - 45.45) | Buy |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.78 | Buy |
Relative Strength Index (14 RSI): | 75.34 | Buy |
Chaikin Money Flow: | 1118573 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.36 - 28.56) | Buy |
Bollinger Bands (100): | (14.7 - 22.78) | Buy |
NGVT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.69 | Sell |
20-day SMA: | 47.36 | Sell |
50-day SMA: | 41.94 | Buy |
200-day SMA: | 43.67 | Buy |
8-day EMA: | 46.81 | Sell |
20-day EMA: | 46.48 | Sell |
50-day EMA: | 43.9 | Buy |
200-day EMA: | 43.55 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.6 | Buy |
20-day SMA: | 23.68 | Buy |
50-day SMA: | 19.33 | Buy |
200-day SMA: | 17.9 | Buy |
8-day EMA: | 29.53 | Buy |
20-day EMA: | 25.45 | Buy |
50-day EMA: | 21.38 | Buy |
200-day EMA: | 19.88 | Buy |
Ingevity Earnings Growth & NGVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and an increase next year of $1.26 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.
Ingevity Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |